The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care
| Autor: | Robert S. McKelvie, George A. Heckman, Debra Isaac, Jessica Simon, John S. Floras, Peter Liu, Heather J. Ross, Nadia Giannetti, Anson Cheung, Karen Harkness, Kori Leblanc, Adam Grzeslo, Marie-Hélène Leblanc, Vivek Rao, J. Malcolm O. Arnold, Shelley Zieroth, Anique Ducharme, Tom Ashton, Justin A. Ezekowitz, Paul Dorian, Estrellita Estrella-Holder, Simon Kouz, Michel D'Astous, Elizabeth Swiggum, Eileen O'Meara, Miroslav Rajda, Gordon W. Moe, Elizabeth Mann, Jeannine Costigan, Haissam Haddad, Bruce Sussex, Jonathan G. Howlett |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
medicine.medical_specialty Canada Palliative care medicine.medical_treatment Cardiac resynchronization therapy Comorbidity Kidney Function Tests Risk Assessment Sleep Apnea Syndromes medicine Humans Sleep study Intensive care medicine Societies Medical Heart transplantation Heart Failure business.industry Palliative Care Sleep apnea Canadian Cardiovascular Society medicine.disease Prognosis Combined Modality Therapy Survival Analysis Clinical trial Treatment Outcome Heart failure Practice Guidelines as Topic Kidney Failure Chronic Female Heart-Assist Devices Cardiology and Cardiovascular Medicine business |
| Zdroj: | The Canadian journal of cardiology. 27(3) |
| ISSN: | 1916-7075 |
| Popis: | The 2011 Canadian Cardiovascular Society Heart Failure (HF) Guidelines Focused Update reviews the recently published clinical trials that will potentially impact on management. Also reviewed is the less studied but clinically important area of sleep apnea. Finally, patients with advanced HF represent a group of patients who pose major difficulties to clinicians. Advanced HF therefore is examined from the perspectives of HF complicated by renal failure, the role of palliative care, and the role of mechanical circulatory support (MCS). All of these topics are reviewed from a perspective of practical applications. Important new studies have demonstrated in less symptomatic HF patients that cardiac resynchronization therapy will be of benefit. As well, aldosterone receptor antagonists can be used with benefit in less symptomatic HF patients. The important role of palliative care and the need to address end-of-life issues in advanced HF are emphasized. Physicians need to be aware of the possibility of sleep apnea complicating the course of HF and the role of a sleep study for the proper assessment and management of the conditon. Patients with either acute severe or chronic advanced HF with otherwise good life expectancy should be referred to a cardiac centre capable of providing MCS. Furthermore, patients awaiting heart transplantation who deteriorate or are otherwise not likely to survive until a donor organ is found should be referred for MCS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect